Searched for
LIFE SCIENCES DIAGNOSTICS
DHR Holdings leases 1.8 lakh sq ft in BengaluruDHR Holding India has leased nearly 1.8 lakh square feet of office space in Bengaluru. The company secured three floors at Sumadhura Capito...- These large-caps have ‘strong buy’ & ‘buy’ recos and an upside potential of up to 20%, according to analystsInvesting, a wise man once said, is a journey; one that needs to be managed carefully. Remember two things: One, there is never a “perfect ...
- How PGIM India's Rs 112 crore Healthcare Fund picks CDMO stocks to generate alphaPGIM India Healthcare Fund generated a 22% return over the past year by over-allocating to high-growth segments like CDMO, specialty pharma...
- Life on Earth has always used four DNA letters, but scientists have created a bigger genetic alphabet and found something unexpectedScientists have demonstrated RNA polymerase can read eight genetic letters. This enzyme accurately transcribes synthetic DNA, which nature ...
- Karnataka signs MoU with INQ Innovation Global to strengthen collaboration with New South WalesThe state of Karnataka is joining forces with New South Wales in Australia to bolster their innovation ecosystems. This agreement will faci...
- Jharkhand on high alert over Swine Flu; Health Minister directs hospitals to reserve beds, ramp up surveillanceJharkhand Health Department is on high alert for potential H1N1 cases. Health Minister Irfan Ansari directed enhanced surveillance and hosp...
- These large-, mid- and small-cap stocks can give more than 20% return in 1 year, according to analystsEven if the ongoing conflict in the Gulf settles anytime soon (and we certainly hope it does), don’t be surprised if the Nifty and Sensex r...
- Six Indian healthtech startups selected for UK-India accelerator programmeLaunched in 2023, the programme seeks to strengthen collaboration between India and the UK in health innovation and help Indian companies p...
- Weekly Top Picks: These stocks scored 10 on 10 on Stock Reports PlusStock Reports Plus, powered by Refinitiv, undertakes detailed company analysis for 4,000+ listed stocks. In addition to detailed company an...
- NFO Insight: Invesco India Pharma and Healthcare Fund opens for subscription. Right time to invest in pharma funds?Invesco India has unveiled an innovative pharma and healthcare fund tailored for investors seeking opportunities in India's burgeoning heal...
- Long-term investing: One reason is good enough, and a must, to own a business. 8 stocks with an upside potential of up to 36%In today’s world, investors cannot assume that correlations that worked in the past will work in exactly the same manner now. We are in a p...
- 17-year-old New Jersey high schooler Edward Kang built an AI tool that reads the retina for autism and ADHD screening and won $175,000 for his groundbreaking researchNew Jersey high schooler Edward Kang, 17, developed RetinaMind, an AI tool that analyzes retinal images to identify patterns linked to auti...
- The Architecture Trap: Why better algorithms won’t fix healthcareIndia’s AI healthcare push faces a critical choice: use technology mainly to streamline existing healthcare transactions or build a prevent...
- NFO Alert: Invesco Mutual Fund announces launch of pharma and healthcare fundInvesco Mutual Fund has launched a new open-ended equity scheme. This fund will invest in India's evolving pharma and healthcare sectors. I...
- These large- and mid-cap stocks can give more than 25% return in 1 year, according to analystsLooking at what happens in the short term is important, as it does have an impact on stock prices. But also always keep an eye on the macro...
- Mid-cap stocks: Time for a change of stance? 6 mid-caps from different sectors with an upside potential up to 29%Sometimes the real market story is not in the headline index. The Nifty and Sensex can be under pressure, and yet, below them, mid- and sma...
- Picking the right pharma stock is getting harder; so pick a portfolio: 20 stocks with -23% to +22% downside to upside potentialFor Indian pharma, the regulatory risk is still real. A US FDA inspection can still cause trouble. A plant making an important product or g...
- Warburg set to buy Seacod-maker Universal NutriScience for Rs 2800 croreWill be 4th acquisition for the US private equity giant in India’s healthsector in four months. Kedaara to make 5x rupee returns on exit.
- ET Health Conclave 2026: Healthcare leaders reimagine the future of medicine through innovation, prevention and technologyFrom AI-powered hospitals and genomics to regenerative medicine and precision cardiology, ET Health Conclave 2026 brought together India's ...
- 5 AI award categories that every AI-innovation platform should nominate themselves inArtificial intelligence is transforming industries with independent reasoning and complex workflow orchestration. New AI products are drivi...
Load More
